DSM : Preview 4Q20 results due 16 February
>We forecast adjusted EBITDA of EUR 383m, 2% above consensus - DSM will report its 4Q20 results on 16 February at 07.00 CET followed by a conference call at 09.00, accessible via . We forecast adjusted EBITDA of EUR 383m, up 3% yoy and 2% above consensus (Vara).We believe Materials could positively surprise - We expect 4Q20 sales of EUR 1,945m, up 1% yoy (volumes 4%, prices -1%) and 2% below consensus. We forecast Nutrition adjusted EBIT...Royal DSM is engaged in the creation of products and services in Life Sciences and Materials Sciences. Co.'s products and services are used globally in range of markets and applications in healthcare, pharmaceutical automotive and chemicals sectors. End markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrics and electronics, life protection and housing. The activities of Co. are grouped into four clusters: Nutrition, Pharma, Performance Materials and Polymer Intermediates.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.